Orion
Ainoleena Turku is a Computational Scientist at Orion Corporation since July 2020. Previously, Ainoleena held the position of Postdoctoral Researcher at Karolinska Institutet, focusing on molecular modeling and ligand design for Class F G protein-coupled receptors, and at the University of Helsinki, specializing in structure-based drug discovery targeting membrane-bound pyrophosphatases. Ainoleena's academic journey includes significant work as a Doctoral Student at the University of Helsinki, with projects on G protein-coupled orexin receptors and mPPases, complemented by a brief research visit to the University of Leeds. Ainoleena's educational background includes a PhD in Pharmaceutics and Drug Design and an Associate Professorship in Pharmaceutical Chemistry at the University of Helsinki, along with master's and bachelor's degrees in Pharmacy. Parental leave periods were also part of Ainoleena's professional timeline.
This person is not in the org chart
This person is not in any teams
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.